Our Company

Meet BenchSci

What sets us apart:

The power of AI

We’re a world leader in biological AI solutions for drug discovery. We’ve been training our AI for almost a decade with data from over 15 million publications.

A global team

We have over 400 employees across diverse backgrounds and experiences, with offices in Toronto, ON and Cambridge, UK.

Founded in 2015

Our founders Tom Leung, David Q. Chen, Elvis Wianda, and Liran Belenzon came together to build a future where medicine is discovered and brought to patients exponentially faster.

Backers who believe

We’re backed by top-tier investment firms who support our vision and our execution.

Investors

BenchSci is backed by leading investors

  • Inovia logo
  • Gradient Ventures logo
  • F Prime logo
  • Golden Venture Partners logo
  • Afore Capital logo
  • Radical Ventures logo
  • 500 Canada logo

Explore our history

Our mission: enabling better, faster, life-saving R&D

Revolutionizing pharmaceutical drug discovery

Our mission is to create a world where cures are discovered and brought to patients exponentially faster.

Unleashing advanced biomedical AI

We’re helping pharmaceutical organizations transform their R&D portfolio with patented machine learning technology.

Our Leadership team

With experience in pharmaceuticals, machine learning, science, and business, our Leadership team is transforming the discovery of life-saving medicines.

Our Advisory Board

Sharing their expertise in life science research and development, culture, and machine learning technology, our Advisory Board is propelling BenchSci’s mission forward.

Join us and do the best work of your life